AI Explained: GenAI Use Cases and Challenges in Healthcare

February 27, 2025

10AM PT / 1PM ET

Registration is now closed. Please check back later for the recording.

Virtual fireside chat image for 'AI Explained: GenAI Use Cases and Challenges in Healthcare ' with industry experts, with a play button icon indicating video content.

AI is enhancing clinical workflows, patient care, and accelerating medical research and drug discovery. With its adoption comes the opportunity to strengthen AI application reliability, safeguard patient data, and advance regulatory compliance for better healthcare outcomes. Dr. Girish N. Nadkarni, a pioneer in AI-driven precision medicine and co-developer of the first FDA-approved AI bioprognostic tool for kidney disease, KidneyIntelX, will share insights on the transformative potential and challenges of GenAI in healthcare.

AI-driven healthcare use cases, from AI-powered diagnostics and risk prediction to document summarization, information extraction, and internal clinical chatbots.
Key risks including faithfulness, accuracy, and data privacy concerns related to PII and PHI.
Best practices for responsible GenAI deployment and regulatory adherence.

AI Explained is our AMA series featuring experts on the most pressing issues facing AI and ML teams.

Can’t attend live? You should still register! Recordings will be available to all registrants after the event.

Featured Speakers

Dr. Girish N. Nadkarni

Icahn School of Medicine at Mount Sinai

Dr. Girish N. Nadkarni is the Fishberg Professor of Medicine, Chair of the Windreich Department of Artificial Intelligence and Human Health, Director of the Hasso Plattner Institute for Digital Health, and Inaugural System Chief of the Division of Data-Driven and Digital Medicine at the Icahn School of Medicine at Mount Sinai. A leading physician-scientist and clinical informaticist, he has authored 376 peer-reviewed studies with over 40,000 citations, driving breakthroughs in AI-driven cardiovascular and kidney care, predictive analytics, and APOL1 genetic risk. As an entrepreneur, he has co-founded AI-based healthcare companies with FDA-approved innovations and leads multiple NIH and industry-funded projects totaling ~$40 million. He also holds numerous AI-related patents, mentors future medical leaders, and serves as Chair of the Taskforce on AI/Digital Health and Associate Editor of NPJ Digital Medicine.

Krishna Gade

Founder and CEO

Fiddler AI

Krishna Gade is the founder and CEO of Fiddler AI, an enterprise AI Observability startup, which focuses on monitoring, explainability, fairness, and responsible AI governance for predictive and generative models. AI Observability is a vital building block and provides visibility and transparency to the entire enterprise AI application stack. An entrepreneur and engineering leader with strong technical experience in creating scalable platforms and delightful consumer products, Krishna previously held senior engineering leadership roles at Facebook, Pinterest, Twitter, and Microsoft.